Brief: CorMedix Inc Reports Second Quarter And Six Month 2023 Financial Results
Aug 8 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. REPORTS SECOND QUARTER AND SIX MONTH 2023
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* CORMEDIX INC Q2 LOSS PER SHARE $0.25
Source text for Eikon: ID:nGNX6kZN15
Further company coverage: CRMD.O
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary